Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Getinge Report Publication Announcement 2017

Nov 10, 2017

2917_rns_2017-11-10_a6fe6d02-7ec2-4c47-ab5b-e6525b90d14a.pdf

Report Publication Announcement

Open in viewer

Opens in your device viewer

Prospectus for Arjo AB (publ) published

November 10, 2017 Gothenburg, Sweden

Getinge's wholly-owned subsidiary Arjo AB (publ) has prepared a prospectus regarding the admission to trading of the company's shares of series B. The prospectus has today been approved and registered by the Swedish Financial Supervisory Authority. Similar to Getinge's shares of series A, Arjo's shares of series A will not be listed.

The prospectus can be obtained from Getinge and SEB and is available at Getinge's website, www.getinge.com and at SEB's website for prospectuses, www.sebgroup.com/prospectuses.

For more information:

Lars Mattsson, Getinge Head of Investor Relations Telephone: +46(0)10 335 00 43 E-mail: [email protected]

Kornelia Rasmussen, Arjo Executive Vice President Marketing Communication and Public Relations Telephone: +46 (0)10 335 58 10 E-mail: [email protected]

About Getinge

Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving everyday life for people, today and tomorrow.

Getinge AB Box 8861 402 72 Gothenburg Sweden

Telephone: +46 (0)10 335 00 00 Email: [email protected]

www.getinge.com